SEASON OF INITIAL DISCOVERY OF TUMOR AS AN INDEPENDENT VARIABLE PREDICTING SURVIVAL IN BREAST-CANCER

被引:32
作者
MASON, BH
HOLDAWAY, IM
STEWART, AW
NEAVE, LM
KAY, RG
机构
[1] AUCKLAND HOSP,DEPT ENDOCRINOL,AUCKLAND 3,NEW ZEALAND
[2] UNIV AUCKLAND,DEPT COMMUNITY HLTH,AUCKLAND,NEW ZEALAND
[3] UNIV AUCKLAND,DEPT SURG,AUCKLAND,NEW ZEALAND
关键词
D O I
10.1038/bjc.1990.28
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The month of initial detection of tumour was recorded in 2, 245 patients with breast cancer and correlated with survival over a follow-up period of 1.5-10 years. Women who initially detected their breast cancer in spring/summer had a significantly longer survival than those detecting their tumour at other times of the year. Overall, this relationship was independent of nodal status, tumour size and hormone receptor status. However, when patients were divided into groups the survival advantage was significantly associated with receptor status and age. Women aged ≥ 50 years with ER-positive and PR-positive tumours who discovered their initial tumour in spring/summer had significantly better survival than those detecting their tumours at other times of the year. Survival was also longer in women aged < 50 years with receptor-negative tumours who initially found their tumours in spring/summer compared with the rest of the year. This study suggests that the season of first detection of a breast cancer relates significantly to the later behaviour of the tumour, and may reflect seasonal changes in hormone dependent growth. © Macmillan Press Ltd., 1990.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 17 条
[1]  
ARMITAGE P, 1987, STATISTICAL METHODS, P435
[2]  
COHEN P, 1983, BREAST CANCER RES TR, V3, P311
[3]  
COHEN P, 1983, CANCER RES, V43, P892
[4]  
DANFORTH D, 1982, SCIENCE, V216, P1003
[5]   MELATONIN INCREASES ESTROGEN-RECEPTOR BINDING-ACTIVITY OF HUMAN-BREAST CANCER-CELLS [J].
DANFORTH, DN ;
TAMARKIN, L ;
LIPPMAN, ME .
NATURE, 1983, 305 (5932) :323-325
[6]   PLASMA MELATONIN AND THE HORMONE-DEPENDENCY OF HUMAN-BREAST CANCER [J].
DANFORTH, DN ;
TAMARKIN, L ;
MULVIHILL, JJ ;
BAGLEY, CS ;
LIPPMAN, ME .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (07) :941-948
[7]  
HARTVEIT F, 1983, CLIN ONCOL, V9, P233
[8]  
HILL SM, 1988, CANCER RES, V48, P6121
[9]  
HOLDAWAY IM, 1982, PRINCIPLES RADIORECE, P255
[10]  
JACOBSON HI, 1977, P AM ASSOC CANC RES, V18, P93